Conference Coverage (AACR)
New Breast/Prostate Cancer Antigen Prepares for Vaccine Trial
Published in Gene Therapy Weekly, May 13th, 1996
Globo H is a breast cancer associated carbohydrate antigen which was initially defined by the murine monoclonal antibody MBr1. G. Ragupathi of the Memorial Sloan-Kettering Cancer Center noted at the 87th Annual Meeting of the American Association for Cancer Research, held April 20-24, 1996, in Washington, DC, that the protein for Globo H was very difficult to synthesize initially. But now that a process has been developed, it can readily be linked with conjugates to create an anticancer vaccine.
"This is a new antigen, people are not familiar with it yet,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1996-05-13)
More Articles from Gene Therapy Weekly
- Conference Coverage (AACR)
Recombinant Vaccinia Virus: Effective Vector for Cancer Vaccines - Conference Coverage (AACR)
Adenovirus-Mediated IL-2 Gene Therapy for Hepatocellular Carcinoma Promising - Conference Coverage (AACR)
HBV-X Protein Plays a Major Role in the Oncogenesis of Hepatocellular Carcinoma - Conference Coverage (AACR)
Human Umbilical Cord Blood Exhibits Antitumor Activity - Conference Coverage (AACR)
Prostate Cancer Gene Therapy Targets Insulin-Like Growth Factors - Ebola Virus
Analysis of Ebola Virus Raises Hope for Vaccine - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
